Advancing allergy science together

FAST-PASE® opens new frontiers for research in immunology, diagnostics, and beyond.

10K+ tests performed

Enabling the next-gen of allergy treatments

Used in 50+ research programs

Innovative
A label-free, multiplex, real-time platform that goes beyond traditional diagnostics.
Validated
Clinically proven performance, reproducible across centers, ready for translational research.
Collaborative
Designed for partnerships, publications, and discoveries that move science forward.

Why Research with Atanis

FAST-PASE® is a controlled system to explore immune mechanisms, test hypotheses and generate reproducible data across allergy and immunology.
Our team of scientists supports every step of the research process. We design experiments, provide and interpret quantitative results and bring the scientific expertise needed to answer your questions.

FAST-PASE enables research across

01
Lead compound identification
Using FAST-PASE® to screen therapeutic candidates.
02
Efficacy Testing during Clinical Trials
Patient stratification, endpoint measurement, longitudinal tracking.
03
Mechanistic studies
Mast-cell biology, receptor dynamics, IgE/IgG interactions.
04
Food & Drug Safety Assessment
Allergenicity testing of novel foods, biologics, excipients.
05
Anaphylactogenicity in Serum Products
Safety evaluation of IVIG, vaccines, plasma-derived products.

Data you can Trust

Clean & reproducible
Data comes from standardized mast-cell lines and strict QC processes, ensuring results are consistent across runs, sites, and cohorts.

Quantitative outputs
FAST-PASE® provides receptor-level numbers and other quantitative factors that can be directly compared across treatments and longitudinal studies.

Trusted in research
Validated across 10k+ samples and already used in leading academic and pharma programs, FAST-PASE® delivers data researchers can rely on with confidence.

Collaboration
Opportunities

We partner with academic groups, hospitals, and industry to advance allergy science. Collaborations include joint clinical studies, grant applications, data-sharing programs and more.
Switzerland
Headquarter
USA
North Carolina
USA
New York
USA
Boston
USA
Nashville
Canada
Toronto
France
Paris
Austria

Let’s design your next experiment together

Our team of scientists can answer any question you may have about the biology of allergy. We design and support research across all aspects of mast-cell biology — from study planning and assay customization to full collaborative projects.

Scientific Leadership

Our scientific advisors and leadership team bring expertise across immunology, biophysics, and clinical diagnostics. Their guidance shapes FAST-PASE®’s development and ensures alignment with the highest research standards.

Frequently Asked Questions

What allergens does FAST-PASE® test for?

We currently test for the most common food allergens (egg, milk, peanut, and cashew), and the increasingly prevalent red meat allergy caused by the Alpha-gal syndrome. New allergens will be added as the panel expands.

How is FAST-PASE® different from other allergy tests?

Traditional tests look only at IgE levels or rely on skin exposure, leading to false positives or unclear results. FAST-PASE® measures a cellular response outside of your body, giving an accurate picture of your allergic reactivity levels, without exposing you to the allergen — all from a simple blood draw.

How long does it take to get results?

Most results are ready within a few days. As soon as your sample is analyzed, your report becomes available through the secure portal, and your provider can review it with you.

Is it safe to use FAST-PASE®?

Yes. FAST-PASE® only requires a small blood sample - no painful skin pricks, no food challenges, and no risk of allergic reactions. It’s the safest choice for both adults and children.

How accurate is it compared to other tests?

FAST-PASE® measures a cellular response, which is expected to correlate more strongly with true clinical allergy than other tests, as has been published in the clinical utility study. Traditional skin-prick tests have about 50% specificity (essentially a coin flip), while FAST-PASE® provides significantly higher accuracy.

Can FAST-PASE® identify the severity of an allergy?

FAST-PASE® will offer insights into reactivity levels in an upcoming update to our test, helping providers understand not only what you’re allergic to, but how strongly.

Is FAST-PASE® covered by insurance?

No insurance is required. FAST-PASE® can be ordered and completed without going through insurance approvals, making the process faster, simpler, and more accessible for families.

Take the test.
Know the truth.

Clinically validated*. Patient-centered.
Safe for children and adults.